GMED vs. SPY
Compare and contrast key facts about Globus Medical, Inc. (GMED) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GMED or SPY.
Key characteristics
| GMED | SPY | |
|---|---|---|
| YTD Return | 20.00% | 11.58% |
| 1Y Return | 12.51% | 29.17% |
| 3Y Return (Ann) | -3.76% | 9.98% |
| 5Y Return (Ann) | 8.48% | 14.95% |
| 10Y Return (Ann) | 9.93% | 12.88% |
| Sharpe Ratio | 0.39 | 2.67 |
| Daily Std Dev | 33.96% | 11.53% |
| Max Drawdown | -47.91% | -55.19% |
| Current Drawdown | -23.92% | -0.21% |
Correlation
The correlation between GMED and SPY is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
GMED vs. SPY - Performance Comparison
In the year-to-date period, GMED achieves a 20.00% return, which is significantly higher than SPY's 11.58% return. Over the past 10 years, GMED has underperformed SPY with an annualized return of 9.93%, while SPY has yielded a comparatively higher 12.88% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GMED vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GMED vs. SPY - Dividend Comparison
GMED has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.27%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.27% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% | 1.81% |
Drawdowns
GMED vs. SPY - Drawdown Comparison
The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for GMED and SPY. For additional features, visit the drawdowns tool.
Volatility
GMED vs. SPY - Volatility Comparison
Globus Medical, Inc. (GMED) has a higher volatility of 20.02% compared to SPDR S&P 500 ETF (SPY) at 3.40%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.